Abstract. The highly potent anti-HIV agent UC781 is being evaluated for use in topical microbicides to prevent HIV transmission. However, UC781 is extremely hydrophobic with poor water solubility, a property that may complicate appropriate formulation of the drug. In this study, we examined the ability of several cyclodextrins, beta-cyclodextrin (βCD), methyl-beta-cyclodextrin (MβCD), and 2-hydroxylpropyl-beta-cyclodextrin (HPβCD), to enhance the aqueous solubility of UC781. Each of the cyclodextrins provided dramatic increases in UC781 aqueous solubility, the order being MβCD>HPβCD>βCD. The complexation constants (K 1:1 ) of the inclusion complexes were determined via a phase solubility technique using high-performance liquid chromatography and showed that UC781 solubility increased linearly as a function of cyclodextrin concentration. Ultraviolet spectroscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, and 2D 1 H ROESY NMR spectroscopy were used to further characterize these UC781/cyclodextrin complexes. The inhibitory potency of UC781 and its HPβCD inclusion complex were evaluated using an in vitro HIV-1 reverse transcriptase inhibition assay The inhibitory potency of the UC781/HPβCD complex was 30-fold greater than that of UC781 alone, showing that the complexed drug is able to provide substantial inhibition of its target. The enhancement of UC781 aqueous solubility is essential for the development of a useful vaginal microbicide dosage form, and our data suggest that UC781/cyclodextrin inclusion complexes may be useful in this context.
INTRODUCTION
The thiocarboxanilide, N-[4-chloro-3-(3-methyl-2-butenyloxy) phenyl]-2-methyl-3-furancarbothioamide (UC781), is a tight-binding HIV-1 non-nucleoside reverse transcriptase (RT) inhibitor (NNRTI) (Fig. 1) . UC781 has been identified as an extremely potent inhibitor of HIV-1 in cell culture [50% effective concentration (EC 50 ), approximately 3.0 ng/mL] (1-3). It belongs to the class of thiocarboxanilide derivatives, the prototype of which (UC-84) was originally reported by Bader et al. (4) . UC781 can neutralize several laboratory and clinical strains of HIV-1 (2), including both syncytium-and nonsyncytium-inducing phenotypes. It has also been shown to inhibit HIV-1 strains which are resistant to nucleoside RT inhibitors with a potency similar to that for inhibition of wild-type virus (5) . Furthermore, UC781 targets HIV-1RTandiseffectiveagainstavarietyofNNRTI-resistantHIV-1 strains. Importantly, resistance to UC781 is only obtained when more than one mutation occurs in the NNRTI binding pocket (6) .
UC781 is under consideration for use in microbicide formulations designed to minimize sexual transmission of HIV-1. The molecule exhibits a number of virologic properties that are important for anti-HIV microbicides (7) . These include inactivation of isolated HIV virions and prevention of cell-to-cell transmission of HIV. Importantly, UC781 also exhibits a "memory effect" (3, 5, 7, 8) . Borkow et al. (7) showed that uninfected cells exposed to UC781 for periods as low as 15 min are protected from subsequent exposure to infectious HIV-1 despite the absence of exogenous drug. These results were confirmed by Liu et al. (8) who also showed that the memory effect of UC781 was specific for drug-cell interaction and not to nonspecific binding of UC781 to the surfaces of culture plate wells. These properties of UC781 are likely related in part to the hydrophobicity of the compound. However, this hydrophobicity also poses huge challenges in the formulation and release of UC781 upon topical administration. UC781 is regarded as belonging to class II of the Biopharmaceutical Classification System (low solubility, high permeation across membranes) (9) . UC781 is a very hydrophobic compound with an intrinsic solubility lower than 30 ng/mL (unpublished data).
No aqueous parenteral formulation of UC781 is currently available for clinical use.
Cyclodextrins have been utilized to improve the aqueous solubility of hydrophobic drugs. Cyclodextrins (CDs) are cyclic (α-1,4)-linked oligosaccharides with different numbers of α-D-glucopyranose units. They are produced from the bacterial enzymatic degradation of starch (10, 11) . Cyclodextrins have a toroidal or cone shape due to the lack of freely rotating bonds between glucopyranose units and possess a hydrophilic outer surface and a hydrophobic inner cavity in which hydrophobic small guest molecules can reside. In addition to this hydrophobic interaction, other interactions such as Van der Waals forces, electrostatic interactions, and hydrogen bonding interactions can also be driving forces for complex formation of guest molecules with CDs (12) . This property provides CDs with the capacity to increase the aqueous solubility of hydrophobic drugs as well as to stabilize drugs (13, 14) . Structures of βCD and its derivatives have been widely reported in the literature (14) .
In this paper, we evaluated the ability of three different cyclodextrins, beta-cyclodextrin (βCD), methyl-beta-cyclodextrin (MβCD), and 2-hydroxylpropyl-beta-cyclodextrin (HPβCD), to enhance the aqueous solubility of UC781. We further characterized these UC781/cyclodextrin complexes by a variety of physicochemical methods. Finally, the bioactivity of the UC781/HPβCD complex was evaluated using an in vitro RT inhibition assay. Our results show that cyclodextrins provide substantial increases both in aqueous solubility and in biological activity of UC781 and suggest that UC781/cyclodextrin inclusion complexes may be important in the development of appropriate formulations of UC781 for use as a topical microbicide to prevent sexual transmission of HIV.
MATERIALS AND METHODS

Materials
UC781 for these studies was initially provided by Biosyn (Huntington, PA, USA). However, the licensing rights to this drug were transferred to CONRAD who provided subsequent supply as needed. βCD (MW, 1,134), MβCD (MW, approximately 1,320; mean degree of substitution, 1.7-1.9), and HPβCD (MW, approximately 1,380; mean degree of substitution, 0.8) were purchased from Spectrum Chemical (Gardena, CA, USA). Deuterated dimethylsulfoxide (DMSO-d6 99.6%) was obtained from Sigma Aldrich (St. Louis, MO, USA). All other reagents used were of reagent grade and all solvents were of high-performance liquid chromatography (HPLC) grade. Milli-Q water was used to prepare buffer solutions and other aqueous solutions.
Phase Solubility Studies
An excess amount of UC781 was added into a sealed 2-mL autosampler screw thread glass vial (Fisher Scientific, Waltham, MA, USA) containing 1 mL distilled water with various concentrations of βCD, MβCD, and HPβCD (from 0 to 0.52 M). The vials were shaken on a horizontal rotary shaker at a speed of 50 rpm at ambient temperature (25°C) for 7 days. The solutions were then filtered through a 0.45-μm nylon disc filter (Millipore, Billerica, MA, USA) to collect a clear solution. All samples were prepared in triplicates. The concentration of UC781 in the UC781/CD inclusion complex solution was determined using HPLC. The assay used the following conditions: a Waters 510 pump and Waters 2487 dual wavelength absorbance detector at 275 nm; column ODS-C18 (4.6×250 mm, 5 μm; Alltech, Columbia, MD, USA); a mobile phase of acetonitrile/water (75:25 v/v); a flow rate of 1 mL/min.
The complexation constant (K 1:1 ) assuming a 1:1 ratio of UC781/cyclodextrin in the complex was calculated from phase solubility diagrams using Eq. 1 (15):
In this equation, K 1:1 is the complexation constant, S 0 is the intrinsic solubility, and the slope is calculated from a graph of the dissolved drug concentration vs. cyclodextrin concentration in the medium. The intrinsic solubility value (S 0 ) of UC781 in the absence of cyclodextrin was determined directly in aqueous media.
UV Absorption Spectroscopy of UC781 and its Complexes with Cyclodextrins
The effect of CDs on the ultraviolet spectroscopy (UV) spectra of UC781 was studied using a NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). All measurements were performed at a constant temperature of 25°C. Different amounts of βCD (0% to 1% w/v), MβCD (0% to 20% w/v), and HPβCD (0% to 20% w/v) were added into a 50% (v/v) aqueous ethanol solution containing a fixed UC781 concentration (1×10 −4 M). UV absorption spectra (220-410 nm) of UC781 in the absence and in the presence of different CD concentrations were determined.
The stoichiometric proportion and complexation constants K 1:1 were evaluated using the Scott equation (Eq. 2) (16):
where C CD and C UC781 are the total molar concentrations of cyclodextrin and UC781, respectively, ΔA is the change in absorbance after complexation of cyclodextrin (ΔA=A UC781 − A CD:UC781 ), K 1:1 is the complexation constant, and Δɛ is the difference of the molar absorptivities for free and complexed . If the plot of C CD /ΔA against C CD yields a straight line, a 1:1 complex between UC781 and cyclodextrins is indicated. Under this circumstance, Eq. 2 can be simplified giving Eq. 3:
The complexation constant K 1:1 (per molar) can be mathematically calculated from Eq. 3 such that:
H rotating frame Overhauser effect spectroscopy (ROESY) was carried out on a Varian Mercury 400 (400 MHz) spectrometer (Varian, Walnut Creek, CA, USA) with a 5-mm sample tube, operating at 400 MHz at 25°C. While deuterated water is typically used in such studies, the poor aqueous solubility of UC781 necessitated the use of DMSO-d6 as solvent in these experiments. DMSO-d6 has a dielectric constant similar to that of water (17) . Additionally, both UC781 and βCD have acceptable solubility in this solvent. No internal reference was used to avoid possible interference with the complexation between UC781 and cyclodextrins; therefore, the solvent signal (2.50 ppm) was used as an internal reference. 2D ROESY was performed in the phasesensitive mode with a spin-lock mixing time of 500 ms. Complexes of UC781 with βCD were prepared by dissolving 1.0×10 −2 M each of UC781 and βCD in DMSO-d6. Control experiments examined similar concentrations of each compound alone.
1 H signals of βCD were assigned as described by Schneider et al. (18) .
Preparation of UC781/Cyclodextrin Solid Complexes and Physical Mixtures
Complexes of UC781 with each of βCD, MβCD, and HPβCD were prepared at a 1:3 molar ratio. The mixture of UC781 and cyclodextrins was dissolved in a solution of 1.5 mL NH 4 OH (28% solution; Sigma, St. Louis, MO, USA) containing 0.8 mL EtOH. The mixture was shaken vigorously and then frozen using liquid nitrogen. The frozen solution was freeze-dried using a Labconco Freezone 6 Freeze-Dryer system (Labconco, Kansas City, MO, USA) for at least 48 h. The freeze-dried samples were gently ground into a fine powder using a mortar and pestle. The powder was placed onto filter paper and then rinsed with 1 mL of 100% acetonitrile to remove noncomplexed UC781. The solubility of UC781 in acetonitrile is greater than 20 mg/mL whereas βCD is practically insoluble. We thus assume that the acetonitrile wash will contain the majority of the noncomplexed drug. The filter was then placed into vacuum oven at 30°C for 30 min to remove any residual solvent.
Physical mixtures of UC781 with the three different cyclodextrins (1:3 molar ratio of UC781/cyclodextrin) were prepared by mixing freeze-dried UC781 powder with freezedried βCD, MβCD, or HPβCD for 2 min on a Fisher Vortex Genie 2® mixer (Fisher Scientific International, Pittsburgh, PA, USA).
Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) analysis was carried out for pure UC781, the three different pure cyclodextrins, physical mixtures of UC781 with each cyclodextrin at a 1:3 molar ratio, and complexes of UC781 with each of βCD, MβCD, and HPβCD. The DSC patterns were recorded on a Perkin-Elmer DSC-7 (Perkin-Elmer, Boston, MA, USA) equipped with a thermal analysis data station. Each sample (3 to 5 mg) was heated in crimped aluminum pans and over a temperature range of 50°C to 200°C at a constant scanning rate of 5°C/min with nitrogen purging (20 mL/min). A blank aluminum pan was used as a reference. The heat of fusion was calibrated with indium standard from Perkin-Elmer (purity, 99.99%; melting point, 157.07°C; ΔH, 20.37 J/g; heating rate, 5°C/min).
Fourier Transform Infrared Spectroscopy
The infrared spectra of UC781, and its complexes with βCD, HPβCD or MβCD in solid state were obtained using a Bio-Rad Excalibur series Fourier transform infrared (FTIR) spectrometer FTS 3000MX (Bio-Rad Laboratories, Hercules, CA, USA) equipped with a Digilab Merlin 3.3 workstation according to the thin solid film method described by Song et al. (19) . A thin solid film of UC781, βCD, MβCD, HPβCD, physical mixtures of UC781 with each cyclodextrin at a 1:1 molar ratio, and complexes of UC781 with each of βCD, MβCD, and HPβCD were cast on a sodium chloride plate from a solution of 70% ethyl alcohol. The selected wave number range used in this study was from 500 to 4,000 cm 
Statistical Analysis
IC 50 values for UC781 in both the noncomplexed and complexed forms were calculated using GraphPad Prism 4.0. Data was analyzed using one-way analysis of variance with Tukey comparison. P < 0.05 represented significant differences.
RESULTS AND DISCUSSION
Phase Solubility Studies For MβCD, complexation constants were also calculated for a 1:2 complex (K 1:2 ) using Eq. 5, from Lofftson et al. (20) :
In this equation, S t and [CD] t correspond to the total UC781 and MβCD concentration, respectively and K 1:1 and K 1:2 represent the complexation constants for the 1:1 and 1:2 complexes, respectively. The . This value was significantly higher than that calculated for K 1:2 for this complex (4.2 M ) and corresponds to the observed significant increase in aqueous solubility of UC781 in the presence of MβCD. The apparent low value of K 1:2 with respect to K 1:1 indicates that the 1:1 complex is the predominant form.
Increases in UC781 solubility in aqueous cyclodextrin solutions are consistent with the formation of inclusion complexes between UC781 and cyclodextrin molecules. Generally, the main driving force for complex formation is the hydrophobic interaction between a poorly water-soluble guest compound, such as UC781, and the apolar cavity of the cyclodextrin molecule. The hydrophobicity and geometry of the guest molecule as well as the cavity size and the derivative groups of cyclodextrin are important for complex formation. In the current study, the enhancement of UC781 solubility is highly dependent on the type of cyclodextrin used. Based on the phase solubility diagrams, MβCD is more effective in solubilizing UC781 in aqueous media compared to HPβCD and βCD.
The different complexation constants found for the different cyclodextrin molecules studied indicate that the derivative groups on the cyclodextrins appear to play an important role in the incorporation of UC781 into the cyclodextrin cavity, since much higher complexation constants were obtained for MβCD and HPβCD. Specifically, physicochemical properties of cyclodextrins are greatly altered upon methylation. MβCD can be dissolved in both organic solvents and water with less hygroscopic and higher surface activity than underivatized cyclodextrins (21) . Furthermore, the cyclodextrin cavity is lengthened upon methylation of the OH (2) and OH (6) groups of the cyclodextrin rim without significant distortion of the ring, and this would enhance the complexation ability of MβCD (22, 23) . These properties lead to greater complexation ability for MβCD with UC781 than for βCD and HPβCD. Even though βCD is a good host molecule for UC781, the relatively poor aqueous solubility of βCD (16.3 mM) limits its utility for use in the enhancement of UC781 aqueous solubility. Our studies suggest that HPβCD and MβCD may be more appropriate candidates for the solubilization of UC781 for use in topical microbicide formulations. 
UV Studies on UC781 Complex
UV spectroscopy was used to further confirm the complexation of UC781 with the three different cyclodextrins in solution. UC781 in an aqueous ethanol solution showed a peak absorbance at 300 nm. The intensity of this peak absorbance increased upon the addition of βCD, HPβCD, and MβCD (data not shown). None of the cyclodextrins showed significant absorption in the wavelength range studied. Maximal changes in UC781 UV absorption were seen at relatively low cyclodextrin concentrations (0.25% βCD, 2.5% HPβCD, and 10% MβCD) and no further changes were noted with increasing cyclodextrin levels.
The change in UV absorption of UC781 in the presence of the cyclodextrins indicates the formation of inclusion complexes and suggests that this complexation involves the UC781 chromophore entering the cyclodextrin cavity (24) (25) (26) . A linear relationship of C CD /ΔA vs. C CD was observed indicating a 1:1 stoichiometric proportionality for the UC781/CD complexes (data not shown). The complexation constant values (K 1:1 ) calculated from the Scott equation were found to be 17, 7, and 10 M −1 for βCD, MβCD, and HPβCD, respectively. The value of K 1:1 calculated from UV data was lower than that obtained from the phase solubility data. This difference is most likely due to the presence of 
DSC Analysis of UC781/Cyclodextrin Complexes
DSC is widely used to study the interaction between drugs and cyclodextrins in the solid state (27) . DSC thermograms for each pure component, physical mixtures, and UC781/MβCD complexes are shown in Fig. 3 . Similar results were observed in DSC thermograms obtained for the complex of UC781/βCD and UC781/HPβCD. The DSC isotherm for UC781 was characterized by a sharp endothermic peak at 131°C. No endothermic peaks were observed for MβCD and HPβCD alone due to their amorphous nature and also for βCD due to dehydration during the lyophilization processing for complex formation (28) . The broadening of the UC781 endothermic peak in thermograms obtained for physical mixtures of UC781 with either HPβCD or MβCD may be due to carrier-induced drug amorphization. No characteristic UC781 endothermic curve was observed in DSC thermograms for solid complexes of UC781 due to the formation of UC781/βCD, UC781/HPβCD, and UC781/MβCD inclusion complexes in the solid state, consistent with the data obtained in our phase solubility and UV spectroscopy studies.
FTIR Spectroscopy Studies of UC781/Cyclodextrin Complexes
FTIR is a useful tool to identify drug-excipient interactions (29, 30) . Figure 4 shows the FTIR spectra of the UC781/MβCD complex in comparison to those for pure UC781, pure MβCD, and a physical mixture of the two. Similar results were observed in FTIR spectrums obtained for the complex of UC781/βCD and UC781/HPβCD. For pure UC781, the absorption peak at 3,437 cm −1 can be attributed to the stretching vibrations (v) of the N-H bond and that at 1,645 cm −1 reflects N-H group bending vibrations (Δ). A substantial decrease in intensity as well as broadening of the v (N-H) and Δ (N-H) bands was noted in the spectrum of the UC781/MβCD complex, suggesting that the N-H group of UC781 is involved in the interaction between UC781 and the cyclodextrin and indicating formation of the complex. No new peaks were observed in the FTIR spectra of the UC781/ MβCD complex, indicating that no chemical bonds were created in formation of this complex.
2D ROESY NMR Spectroscopy of UC781/Cyclodextrin Complexes
We carried out 2D ROESY NMR studies to predict the structure of the UC781/βCD complex. Due to random substitution of MβCD and HPβCD, these studies were conducted for the UC781/βCD complex only. Furthermore, as indicated in the "Materials and Methods" section, these ); UC781/HPβCD complex (6.0 μg/mL) ( ); UC781/HPβCD complex (3.0 μg/mL) ( ); UC781/HPβCD complex (1.5 μg/mL) ( ). **P<0.01 compared to the gel formulation of noncomplexed UC781 studies were conducted in DMSO-d6 due to solubility constraints. Figure 1 shows the numbered protons of the UC781 molecule. The entire NMR spectrum is shown in Fig. 5 . Crosspeaks were observed between the 5,6,7 protons on the benzene ring of UC781 and the 3′,5′ protons of βCD and between the N-H proton of UC781 and OH2 and OH3 of βCD, indicating very close interaction of UC781 and βCD in the liquid state. This suggests that the complex formed between UC781 and βCD involves the aromatic ring and N-H group of UC781 entering the βCD cavity. These cross-peaks were not observed in spectra obtained for pure UC781 or pure βCD.
Due to random substitution of the βCD derivatives MβCD and HPβCD, these studies were conducted for the UC781/βCD complex only. Given the extremely low solubility of UC781 in D 2 O and the same for βCD in deuterated organic solvent, high-quality NMR spectra would not be possible using D 2 O or other deuterated cosolvent. Therefore, the drug and βCD were dissolved in DMSO-d6 as both βCD and UC781 have a high degree of solubility in this solvent. In addition, the relative magnitude of the dielectric constants of DMSO and H 2 O (ɛ=46.8 and 80, respectively) are similar; therefore, the essential feature of the interaction of UC781 with βCD in DMSO should be similar to that in water (17, 31) . Our 2D ROESY results, considered together with the phase solubility, UV and FTIR spectroscopic, and DSC data, indicate that the benzyl ring of UC781 is included into the cyclodextrin hydrophobic cavity while the N-H group of the thioamide functionality interacts with OH2 and OH3 of βCD on the primary side. This suggests that UC781 enters the cyclodextrin cavity when the inclusion complex is formed and also has a preferred fixed orientation within the cyclodextrin cavity.
Inhibition of HIV Reverse Transcriptase by UC781/HPβCD Complexes
An in vitro HIV RT inhibition assay was used to study the anti-HIV activity of the complexed form of UC781 with HPβCD compared to noncomplexed UC781. Figure 6 shows that the inhibition of RT by the UC781/HPβCD complex is dose-dependent. Currently, a UC781-containing gel product (50 μg/mL of UC781 dispersed in an aqueous-based gel matrix) developed by Biosyn is being evaluated as a microbicide product in phase 1 clinical trials overseen by CON-RAD. We used this gel to compare inhibitory activity with three different UC781/HPβCD complexes (containing 1.5, 3.0, or 6.0 μg/mL UC781). The half maximal inhibitory potency (IC 50 ) for each was calculated. As seen in Fig. 7 , the inhibitory activity of each of the UC781/HPβCD complexes was substantially better (up to tenfold) than that of the gel-formulated drug (P<0.01). We hypothesize that this enhanced bioactivity is due to the aqueous solubility of the UC781/HPβCD complexes compared to that of the noncomplexed UC781 in the aqueous-based gel matrix.
CONCLUSION
This study shows that UC781 can form inclusion complexes with various cyclodextrins, including βCD, HPβCD, and MβCD, and that these complexes provide substantial increases in the aqueous solubility of the virtually waterinsoluble drug. Phase solubility and 2D 1 H NMR data suggest that the UC781/cyclodextrin interaction involves stable 1:1 stoichiometric complexes of the cyclodextrin and UC781. Importantly, the inhibitory potency of the cyclodextrin complexed form of UC781 was greatly increased compared to that of the noncomplexed form in the aqueous-based gel formulation currently being evaluated in phase 1 clinical trials.
Our data suggest that the use of UC781/cyclodextrin complexation has the potential to greatly reduce the amount of UC781 required in a formulated biologically active microbicide product without significant loss of biological activity, leading to reduced cost per dose of the microbicide product. Furthermore, the dramatic increases in aqueous solubility of UC781 afforded by the complexation approach will enable new formulation technologies to be tested in the development of new more effective anti-HIV microbicide products.
